Kidney function on semaglutide — eGFR and UACR improvements

I've been tracking my kidney function obsessively since starting semaglutide 14 months ago. Background: T2D for 8 years, mild diabetic kidney disease (CKD stage 2-3a), was on max dose ACE inhibitor. The FLOW trial data was what convinced my nephrologist to add semaglutide. Here are my results: | Marker | Baseline (Oct 2024) | 6 Months | 12 Months | 14 Mo (Now) | Goal | |--------|-------------------|----------|-----------|-------------|------| | eGFR | 52 mL/min | 48 mL/min | 56 mL/min | 58 mL/min | >60 | | Creatinine | 1.24 mg/dL | 1.31 mg/dL | 1.18 mg/dL | 1.14 mg/dL | <1.2 | | UACR | 186 mg/g | 124 mg/g | 82 mg/g | 68 mg/g | <30 | | BUN | 28 mg/dL | 26 mg/dL | 22 mg/dL | 20 mg/dL | 6-24 | | Cystatin C | 1.42 mg/L | 1.38 mg/L | 1.18 mg/L | 1.12 mg/L | 0.6-1.0 | A few things to note: 1. eGFR DIPPED at 6 months before improving — this is the hemodynamic effect documented in FLOW (like SGLT2 inhibitors) 2. UACR dropped 63% — this is the big one. Albuminuria reduction is the strongest predictor of kidney protection. 3. I'm almost back to CKD stage 2 from stage 3a. My nephrologist is genuinely excited. Anyone else tracking kidney function?